account_balance
Investment manager · 13F filer · SEC CIK 1601086
Armistice Capital, LLC
Reported value$3.61Bas of Jun 30, 2026
Positions323 169 new, 97 sold out
Top 10 weight27%MDGL alone is 4%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
MDGL
Madrigal Pharmaceuticals INC
4.3%Added
SUPN
Supernus Pharmaceuticals
3.4%Added
CYTK
Cytokinetics INC
2.8%Added
INCY
Incyte Corp
2.8%Added
NBIX
Neurocrine Biosciences INC
2.5%Trimmed
TVTX
Travere Therapeutics INC
2.5%Trimmed
AGIO
Agios Pharmaceuticals INC
2.5%Trimmed
PTCT
Ptc Therapeutics INC
2.4%Trimmed
UNH
Unitedhealth Group INC
2.1%Added
FRPT
Freshpet INC
2.1%Added
313 others
72.6%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed